About the Report:
Japan is among the most developed industrialised nations in terms of science and technology (S&T). As innovation in industrial biotechnology is of long-standing priority in the national S&T policy, Japanese companies, often supported by large international trading houses or by governmental institutions, are continuously on alert for innovations abroad. This constitutes an excellent opportunity for European start-ups and SMEs which develop innovative products or technologies to partner with Japanese stakeholders. However, large distances and different business cultures must be patiently bridged to succeed in business development. Thus, this report titled 'Industrial (“White”) Biotechnology in Japan: Company Activities and Government Programs – and How to Become Involved. A Primer for European SMEs' describes some of the mechanisms by which European SMEs can get involved and how such partnering can be achieved.
About the Expert
Rolf SCHMID, Senior Consultant & CEO, Bio4Business - SCHMID Rolf
The recording of the past webinar covering this topic is available for online viewers here. (Once you are logged in, look for the link below the "After event information")
Picture: Forest - National Museum of Nature and Science, Tokyo
Copyright: Wikipedia in the public domain
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026